p21 in Cancer Research
null Shamloo et al, 2019, Cancers CrossRef
Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients
S M Hasan Mahmud et al, 2021, Briefings in Bioinformatics CrossRef
Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio
Marike W. van Gisbergen et al, 2021, Frontiers in Oncology CrossRef
An Electrophilic Deguelin Analogue Inhibits STAT3 Signaling in H-Ras-Transformed Human Mammary Epithelial Cells: The Cysteine 259 Residue as a Potential Target
Sung-Jun Hong et al, 2020, Biomedicines CrossRef
Therapeutic Potential of Genus Pongamia and Derris: Phytochemical and Bioactivity
Bharat Goel et al, 2021, Mini-Reviews in Medicinal Chemistry CrossRef
Metabolic exhaustion and casein kinase 1α drive deguelin-induced premature red blood cell death
Mohammad A. Alfhili et al, 2023, Xenobiotica CrossRef
Deguelin inhibits the proliferation of human multiple myeloma cells by inducing apoptosis and G2/M cell cycle arrest: Involvement of Akt and p38 MAPK signalling pathway
Kening Sun et al, 2024, Acta Pharmaceutica CrossRef
The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts
Masatoshi Nukui et al, 2018, Viruses CrossRef
Recent Advances in Chemotherapeutic Implications of Deguelin: A Plant- Derived Retinoid
Manzoor A. Mir et al, 2021, The Natural Products Journal CrossRef
Flavonoid-Based Cancer Therapy: An Updated Review
Elham Hosseinzadeh et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef
Research Status of Mouse Models for Non-Small-Cell Lung Cancer (NSCLC) and Antitumor Therapy of Traditional Chinese Medicine (TCM) in Mouse Models
Hongkui Chen et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
Elizabeth Varghese et al, 2018, Cancers CrossRef